Interestingly, about 10% of PDAC patients who develop lung metastasis survive longer than those with metastasis to other organs, particularly the liver. In some cases, PDAC patients with untreated ...

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Major advances in cancer control will be greatly aided by early detection for diagnosing and treating cancer in its preinvasive state before metastasis. Unfortunately, for pancreatic ductal ...

Researchers have found in a randomised trial that High-dose IV vitamin C combined with standard chemotherapy significantly ...

About GOBLET Cohort 5 The mFOLFIRINOX cohort of the Phase 1/2 GOBLET study is designed to evaluate newly diagnosed metastatic PDAC patients treated with pelareorep + mFOLFIRINOX with or without ...

Real-world use of supportive medications to prevent and manage key adverse events during first-line (1L) treatment of metastatic pancreatic adenocarcinoma ... resected pancreatic ductal adenocarcinoma ...